Key result
Higher CVD risk scores linked to at least ~16% higher incident cancer risk.
Why the study?
Cardiovascular disease and cancer share risk factors, making it plausible that CVD risk scores and cardiovascular health metrics could predict incident cancer risk. A synthesis of prospective studies examining these associations was needed.
Do cardiovascular disease risk scores and cardiovascular health metrics predict incident cancer in adults aged 18 years or older?
Systematic Review (n=970,527)
Yes
Do cardiovascular disease risk scores and cardiovascular health metrics predict incident cancer in adults aged 18 years or older?
Worse cardiovascular disease risk scores and poorer cardiovascular health metrics consistently predict a higher incidence of overall, lung, and colorectal cancer, underscoring the dual benefit of optimal cardiovascular health in reducing both cardiovascular and malignancy risks.
Answers are grounded in this paper and cite their sources.
Supports shared risk counseling across cardiovascular and oncology prevention; leaves open whether CVD risk scores should guide targeted cancer screening.
BACKGROUND: Cardiovascular disease (CVD) and cancer are leading global causes of morbidity and mortality. Given the shared risk factors, it is plausible that CVD risk scores and cardiovascular health (CVH) metrics could predict cancer risk. OBJECTIVES: The authors sought to identify and summarize studies examining the association between CVD risk scores, CVH metrics, and incident cancer. METHODS: A systematic search of 4 databases (Embase, PubMed, Scopus, Web of Science: Core) was conducted in April 2024 without language or date restrictions. Five reviewers (G.H., J.K., S.J.K., M.H., V.L.R.) independently screened records using Covidence software and extracted data from eligible prospective studies (adults aged ≥18 years; cancer incidence as outcome; CVD risk scores or CVH metrics as exposure). RESULTS: Of 4,165 records screened, 13 studies (14 CVD or CVH metrics) were included. Heterogeneity between scales precluded a meta-analysis. Four studies evaluated CVD risk scores (eg, atherosclerotic CVD) and 10 reported CVH metrics (eg, the American Heart Association's Life's Simple 7). Sample sizes ranged from 1,880 to 342,226, with median follow-up from 8.1 to 29.6 years. The majority included all types of cancer (71.4%), including breast, lung, colorectal, and prostate cancer types, with cancer events ranging from 387 to 11,643. Higher CVD risk scores were consistently associated with increased cancer risk incidence (HRs: 1.16-3.71). Ideal CVH metrics were associated with reduced risk (HRs: 0.49-0.95). CONCLUSIONS: Despite heterogeneity in CVD risk metrics and cancer types, most studies suggested that worse CVD risk scores or CVH metrics predict greater cancer risk. Future studies should focus on specific CVD risk metrics and cancer types to produce evidence suitable for a meta-analysis.
No takes yet. Share an insight, caveat, or question.
Henríquez-Santos et al. (2025) conducted a systematic review in Cardiovascular risk and incident cancer (n=970,527). Cardiovascular disease risk scores (ASCVD/PCE, SCORE, Framingham Risk Score) and cardiovascular health metrics (AHA Life's Simple 7, Life's Essential 8) vs. Lower vs higher cardiovascular disease risk scores or healthier (ideal) vs unhealthier (poor) cardiovascular health metrics (and continuous per-unit increases) was evaluated on Incident cancer (all-type and site-specific) (HR 1.16-3.71 (higher CVD risk scores); HR 0.49-0.95 (ideal CVH metrics)). Higher CVD risk scores were associated with increased cancer incidence, whereas ideal cardiovascular health metrics were associated with reduced cancer risk.
Synapse has enriched 10 related papers. Consider them for comparative context: